Other Clinical Trial - A Study of Abemaciclib (LY2835219) in Participants

Updated 05/14/2024

Status Completed

Clinical Trial Summary

The main purpose of this study is to evaluate the effectiveness of the study drug known as abemaciclib versus docetaxel in participants with stage IV squamous non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Non-Small Cell Lung Cancer Stage IV

Clinical Trial Details

NCT number	NCT02450539
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 2
Start date	August 6, 2015
Completion date	July 29, 2020

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02047344` - Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC	Phase 2
	Terminated	`NCT00766246` - Phase II Avastin Trial for Stage IIIB/IV NSCLC	Phase 2
	Active, not recruiting	`NCT04108026` - Immunotherapy in Patient With Poor General Condition	Phase 2
	Active, not recruiting	`NCT04432207` - A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer	Phase 1
	Recruiting	`NCT05598853` - Intrathecal Double Checkpoint Inhibition	Phase 1
	Not yet recruiting	`NCT06117644` - The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC
	Terminated	`NCT01348126` - Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer	Phase 2/Phase 3
	Completed	`NCT01086254` - SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer	Phase 2
	Terminated	`NCT01798485` - A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC	Phase 3
	Recruiting	`NCT06348199` - A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer	Phase 3
	Terminated	`NCT04289259` - Tumor Mutational Burden in Lung Cancer Patients
	Recruiting	`NCT05818449` - Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)	N/A
	Completed	`NCT03526900` - Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis	Phase 2
	Completed	`NCT02176369` - Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial	Phase 2
	Terminated	`NCT03275597` - Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition	Phase 1
	Active, not recruiting	`NCT05055167` - Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC	Phase 2
	Not yet recruiting	`NCT03532698` - Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
	Not yet recruiting	`NCT03543683` - Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC